4.2 Review

Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness

Journal

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
Volume 70, Issue 1, Pages 17-28

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1369/00221554211048951

Keywords

angiogenesis; cancer; DLK1; glioblastoma; stem cell; stemness; tissue differentiation; tumor heterogeneity; tumor immune infiltrate; tumor microenvironment

Categories

Funding

  1. Ragnar Soderberg Foundation
  2. Swedish Cancer Society
  3. Swedish Research Council
  4. Swedish Childhood Cancer Fund
  5. Ollie & Elof Ericssons Foundation
  6. Swedish Brain Foundation (Hjarnfonden)
  7. Crafoord Foundation

Ask authors/readers for more resources

DLK1 is an important gene that regulates stem cells and tissue differentiation, with roles in various cancer types. Recent research shows that DLK1 plays a key role in maintaining tumor stem cell characteristics, with its expression and cleavage patterns finely regulated. Studying the regulation and signaling of DLK1 may help in intervening cancer stem cell properties.
DLK1 is a maternally imprinted, paternally expressed gene coding for the transmembrane protein Delta-like homologue 1 (DLK1), a non-canonical NOTCH ligand with well-described roles during development, and tumor-supportive functions in several aggressive cancer forms. Here, we review the many functions of DLK1 as a regulator of stem cell pools and tissue differentiation in tissues such as brain, muscle, and liver. Furthermore, we review recent evidence supporting roles for DLK1 in the maintenance of aggressive stem cell characteristics of tumor cells, specifically focusing on central nervous system tumors, neuroblastoma, and hepatocellular carcinoma. We discuss NOTCH -dependent as well as NOTCH-independent functions of DLK1, and focus particularly on the complex pattern of DLK1 expression and cleavage that is finely regulated from a spatial and temporal perspective. Progress in recent years suggest differential functions of extracellular, soluble DLK1 as a paracrine stem cell niche-secreted factor, and has revealed a role for the intracellular domain of DLK1 in cell signaling and tumor stemness. A better understanding of DLK1 regulation and signaling may enable therapeutic targeting of cancer stemness by interfering with DLK1 release and/or intracellular signaling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available